Caption Management’s Avita Medical RCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-200,400
Closed -$1.05M 1642
2022
Q3
$1.05M Sell
200,400
-6,300
-3% -$38.9K 0.01% 852
2022
Q2
$982K Sell
206,700
-10,200
-5% -$63K 0.01% 887
2022
Q1
$1.84M Buy
+216,900
New +$2M 0.02% 781

Other funds holding RCEL

Caption Management's RCEL Position: Q4 2022 in Review

Caption Management sold out of Avita Medical (RCEL) in Q4 2022, closing a stake of 106,959 shares — an estimated $563K sold.

Caption Management first reported a position in RCEL in Q1 2022 and held it in 3 quarters. The position peaked at $563K in Q3 2022. 52 funds tracked by Wall St. Rank hold RCEL as of Q4 2022.

  • Caption Management reported no remaining Avita Medical position as of Q4 2022 after selling out during the quarter.
  • Caption Management sold 106,959 Avita Medical shares in Q4 2022, an estimated $563K.
  • Caption Management first reported a position in Avita Medical in Q1 2022 and held it in 3 quarters.
  • Caption Management's Avita Medical position peaked at $563K in Q3 2022.
  • 52 funds tracked by Wall St. Rank held Avita Medical as of Q4 2022.

Based on Caption Management's 13F filing for Q4 2022, filed 14 Feb 2023.